Cargando…
TDP-43 as a possible biomarker for frontotemporal lobar degeneration: a systematic review of existing antibodies
Frontotemporal lobar degeneration (FTLD) is one of the leading causes of dementia after Alzheimer’s disease. A high-ranking candidate to become a diagnostic marker for a major pathological subtype of FTLD is the transactive response DNA binding protein of 43 kDa (TDP-43). The main objective is to el...
Autores principales: | Goossens, Joery, Vanmechelen, Eugeen, Trojanowski, John Q, Lee, Virginia MY, Van Broeckhoven, Christine, van der Zee, Julie, Engelborghs, Sebastiaan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4380254/ https://www.ncbi.nlm.nih.gov/pubmed/25853864 http://dx.doi.org/10.1186/s40478-015-0195-1 |
Ejemplares similares
-
Neuron loss and degeneration in the progression of TDP-43 in frontotemporal lobar degeneration
por: Yousef, Ahmed, et al.
Publicado: (2017) -
FUS pathology defines the majority of tau- and TDP-43-negative frontotemporal lobar degeneration
por: Urwin, Hazel, et al.
Publicado: (2010) -
Diagnostic value of cerebrospinal fluid tau, neurofilament, and progranulin in definite frontotemporal lobar degeneration
por: Goossens, Joery, et al.
Publicado: (2018) -
The genetics and neuropathology of frontotemporal lobar degeneration
por: Sieben, Anne, et al.
Publicado: (2012) -
TDP-43 pathology in the retina of patients with frontotemporal lobar degeneration
por: Dijkstra, Anke A., et al.
Publicado: (2023)